Scilex Holding (SCLX) Cash from Operations (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Cash from Operations of 1100000.0 for Q1 2026, down 81.69% year-over-year from 6007000.0 in Q1 2025, and up 106.3% on a QoQ basis from 17471000.0 in Q4 2025.

Scilex Holding (SCLX) Cash from Operations (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Cash from Operations for 7 consecutive years, with 1100000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Operations fell 81.69% year-over-year to 1100000.0; the TTM figure through Mar 2026 stood at 1091000.0 (down 106.83% YoY), while the FY2025 annual figure was 3816000.0, down 80.28% from the prior year.
  • Cash from Operations came in at 1100000.0 for Q1 2026 at Scilex Holding, up from 17471000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 9391000.0 in Q1 2024, with the low at 17471000.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 1041176.47, with a median of 2311000.0 recorded in 2024.
  • The largest YoY upside for Cash from Operations was 1884.07% in 2022 against a maximum downside of 2136.1% in 2022.
  • Year by year, Cash from Operations stood at 725000.0 in 2022, then plunged by 643.45% to 5390000.0 in 2023, then jumped by 147.01% to 2534000.0 in 2024, then sank by 789.46% to 17471000.0 in 2025, then jumped by 106.3% to 1100000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 1100000.0, 17471000.0, and 8187000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.51 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.83 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.92 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.54 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.62 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 -17.47 Mn
Dec 31, 2025 -17.47 Mn
Sep 30, 2025 8.19 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 7.09 Mn
Jun 30, 2025 7.09 Mn
Mar 31, 2025 6.01 Mn
Mar 31, 2025 6.01 Mn
Dec 31, 2024 2.53 Mn
Dec 31, 2024 2.53 Mn
Sep 30, 2024 5.11 Mn
Sep 30, 2024 5.11 Mn
Jun 30, 2024 2.31 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 9.39 Mn
Mar 31, 2024 9.39 Mn
Dec 31, 2023 -5.39 Mn
Dec 31, 2023 -5.39 Mn